Related Experiment Video
Updated: Jun 20, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Langerhans cell histiocytosis, a case of Letterer Siwe disease
Chaitanya Pant1, Phillip Madonia, Sami L Bahna
1Louisiana State University Health Sciences Center, Department of Medicine/Pediatrics, Shreveport, LA, USA.
Insights
This case study details an infant with Langerhans cell histiocytosis, a rare condition. Salvage therapy with cladribine and cytarabine effectively treated the infant after initial chemotherapy failed.
Area of Science:
- Pediatric Oncology
- Dermatology
- Hematology
Background:
- Langerhans cell histiocytosis (LCH) is a rare clonal proliferative disorder of Langerhans cell precursors.
- Infantile LCH often presents with multisystem involvement, including skin, bone, and visceral organs.
Observation:
- An 8-month-old infant presented with a chronic rash, fever, poor feeding, and abdominal distension.
- Initial workup revealed anemia, thrombocytopenia, and hepatosplenomegaly, leading to a suspicion of LCH.
- Diagnosis was confirmed via skin biopsy.
Findings:
- The patient initially improved with vinblastine and prednisone chemotherapy but relapsed.
- Combination salvage therapy with cladribine (2CdA) and cytarabine (Ara-C) resulted in complete resolution of LCH.
- The patient was subsequently referred for a bone marrow transplant.
Implications:
- This case highlights the potential efficacy of cladribine and cytarabine combination salvage therapy for refractory or relapsed LCH in infants.
- Early diagnosis and appropriate treatment strategies are crucial for improving outcomes in pediatric LCH.
- Further research into novel therapeutic approaches for LCH is warranted.
Abstract:
An 8-month-old male infant presented with a progressively worsening generalized rash of 5-6 months duration, fever, poor feeding, and abdominal distension. An initial laboratory workup revealed anemia, thrombocytopenia, and hepatosplenomegaly. The patient was started on i.v. antibiotics, and a working diagnosis of Langerhans cell histiocytosis was reached that was later confirmed with a skin biopsy. Subsequently, the patient received first-round chemotherapy with vinblastine and prednisone, on which he appeared to improve clinically; however, he soon relapsed. He then received combination salvage therapy with cladribine (2CdA) and cytarabine (Ara-C) for three cycles. The patient responded well to this regimen with resolution of his condition. The patient was then referred for a bone marrow transplant.
Related Concept Videos
Lysosomal Hydrolases
Leishmaniasis